These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21464895)

  • 1. Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda.
    Babigumira JB; Castelnuovo B; Stergachis A; Kiragga A; Shaefer P; Lamorde M; Kambugu A; Muwanga A; Garrison LP
    PLoS One; 2011 Mar; 6(3):e18193. PubMed ID: 21464895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda.
    Nakiwogga-Muwanga A; Katabira E; Kiragga A; Kambugu A; Nakibuuka-Lubwama E; Manabe YC; Alamo ST; Colebunders R
    Int J STD AIDS; 2014 Feb; 25(2):105-12. PubMed ID: 23970633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda.
    Babigumira JB; Castelnuovo B; Lamorde M; Kambugu A; Stergachis A; Easterbrook P; Garrison LP
    BMC Health Serv Res; 2009 Oct; 9():192. PubMed ID: 19845963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacy-only refill program at a large HIV clinic in Uganda: experience and satisfaction of patients.
    Nakiwogga-Muwanga A; Katabira E; Sempa J; Kambugu A; Nakibuuka-Lubwama E; Lamorde M; Mawejje J; Colebunders R
    J Int Assoc Provid AIDS Care; 2014; 13(3):264-8. PubMed ID: 23744774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective.
    Marcellusi A; Viti R; Russo S; Andreoni M; Antinori A; Mennini FS
    Clin Drug Investig; 2016 May; 36(5):377-87. PubMed ID: 26940802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs of HIV antiretroviral therapy adherence programs and impact on health care utilization.
    Sansom SL; Anthony MN; Garland WH; Squires KE; Witt MD; Kovacs Andrea A; Larsen RA; Valencia R; Pals SL; Hader S; Weidle PJ; Wohl AR
    AIDS Patient Care STDS; 2008 Feb; 22(2):131-8. PubMed ID: 18260804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Peer-Delivered HIV Self-Tests for MSM in Uganda.
    Okoboi S; Castelnuovo B; Van Geertruyden JP; Lazarus O; Vu L; Kalibala S; Kamara Y; Ochanda PN; King R; Mujugira A
    Front Public Health; 2021; 9():651325. PubMed ID: 33816426
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
    Medina Lara A; Kigozi J; Amurwon J; Muchabaiwa L; Nyanzi Wakaholi B; Mujica Mota RE; Walker AS; Kasirye R; Ssali F; Reid A; Grosskurth H; Babiker AG; Kityo C; Katabira E; Munderi P; Mugyenyi P; Hakim J; Darbyshire J; Gibb DM; Gilks CF;
    PLoS One; 2012; 7(4):e33672. PubMed ID: 22545079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of two-way texting for post-operative follow-up in Zimbabwe's voluntary medical male circumcision program.
    Babigumira JB; Barnhart S; Mendelsohn JM; Murenje V; Tshimanga M; Mauhy C; Holeman I; Xaba S; Holec MM; Makunike-Chikwinya B; Feldacker C
    PLoS One; 2020; 15(9):e0239915. PubMed ID: 32997710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study.
    Kahn JG; Marseille E; Moore D; Bunnell R; Were W; Degerman R; Tappero JW; Ekwaru P; Kaharuza F; Mermin J
    BMJ; 2011 Nov; 343():d6884. PubMed ID: 22074713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.
    Pitter C; Kahn JG; Marseille E; Lule JR; McFarland DA; Ekwaru JP; Bunnell R; Coutinho A; Mermin J
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):336-43. PubMed ID: 17327758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis.
    Hamers RL; Sawyer AW; Tuohy M; Stevens WS; Rinke de Wit TF; Hill AM;
    AIDS; 2012 Aug; 26(13):1663-72. PubMed ID: 22695297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review.
    Mdege ND; Chindove S; Ali S
    Health Policy Plan; 2013 May; 28(3):223-36. PubMed ID: 22738755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda.
    Babigumira JB; Sethi AK; Smyth KA; Singer ME
    Pharmacoeconomics; 2009; 27(11):963-73. PubMed ID: 19888795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda.
    Nuwagira E; Lumori BAE; Muhindo R; Kanyesigye M; Amir A; Muyindike W; Muzoora C
    AIDS Res Ther; 2021 Mar; 18(1):7. PubMed ID: 33743748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
    Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
    PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.
    Ouattara EN; Robine M; Eholié SP; MacLean RL; Moh R; Losina E; Gabillard D; Paltiel AD; Danel C; Walensky RP; Anglaret X; Freedberg KA
    Clin Infect Dis; 2016 Jun; 62(11):1454-1462. PubMed ID: 26936666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a savings-led family-based economic empowerment intervention for AIDS-affected adolescents in Uganda: A four-year follow-up on efficacy and cost-effectiveness.
    Tozan Y; Sun S; Capasso A; Shu-Huah Wang J; Neilands TB; Bahar OS; Damulira C; Ssewamala FM
    PLoS One; 2019; 14(12):e0226809. PubMed ID: 31891601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of increased contraceptive coverage using family planning benefits cards compared with the standard of care for young women in Uganda.
    Nuwamanya E; Babigumira JB; Svensson M
    Contracept Reprod Med; 2023 Feb; 8(1):21. PubMed ID: 36782307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.